Venus Remedies gets marketing approval from Israel, Colombia for two oncology drugs EP News Bureau Dec 29, 2023 The company has received marketing authorisation for docetaxel from Israel and cytarabine from Colombia
Venus Remedies gets marketing approval for six chemotherapy drugs from Philippines EP News Bureau Oct 16, 2023 Venus Remedies' oncology wing has also secured marketing authorisation from Myanmar for another chemotherapy drug oxaliplatin
Venus Remedies gets marketing approval for gemcitabine and docetaxel from Serbia EP News Bureau Sep 20, 2023 With this, the company has secured 511 marketing approvals for its oncology products across 66 countrles
Venus Remedies gets marketing authorisation for cancer drugs from Philippines, Paraguay, Georgia and… EP News Bureau Jul 31, 2023 With this, the number of marketing approvals for its oncology products across 76 countries has gone up to 506
Venus Remedies gets marketing approvals from Oman, Malaysia, Bosnia and Trinidad & Tobago EP News Bureau Jul 5, 2023 With this, the number of marketing approvals for its oncology products across 75 countries has gone up to 503
Venus Remedies gets marketing approval from Saudi for Docetaxel EP News Bureau Jun 1, 2023 This marketing authorisation from the largest GCC market will enable Venus Remedies to establish a strong foothold in GCC and MENA…
US FDA approves additional indication of darolutamide in combination with docetaxel EP News Bureau Aug 9, 2022 The approval is based on positive results of the phase-III Arasens trial that demonstrated darolutamide plus Androgen Deprivation…